🇺🇸 FDA
Pipeline program

IBI3016

CIBI3016A201

Phase 2 small_molecule active

Quick answer

IBI3016 for Hypertension is a Phase 2 program (small_molecule) at Innovent Biologics (Suzhou) Co. with 2 ClinicalTrials.gov record(s).

Program details

Company
Innovent Biologics (Suzhou) Co.
Indication
Hypertension
Phase
Phase 2
Modality
small_molecule
Status
active

Clinical trials